Detailed information for compound 559604

Basic information

Technical information
  • TDR Targets ID: 559604
  • Name: phenylammonium; phosphenic acid
  • MW: 175.122 | Formula: C6H10NO3P+
  • H donors: 2 H acceptors: 3 LogP: 0.01 Rotable bonds: 0
    Rule of 5 violations (Lipinski): 1
  • SMILES: [NH3+]c1ccccc1.[O-][PH+](=O)O
  • InChi: 1S/C6H7N.HO3P/c7-6-4-2-1-3-5-6;1-4(2)3/h1-5H,7H2;(H,1,2,3)/p+1
  • InChiKey: MFZHIZHQOBGKFY-UHFFFAOYSA-O  

Network

Hover on a compound node to display the structore

Synonyms

  • phenylazanium; phosphenic acid
  • 33921-12-9
  • ANILINE, HYDROGEN PHOSPHITE
  • Anilinium hydrogen phosphite

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major zeta tubulin, putative Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major gamma-tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major delta tubulin, putative Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major alpha tubulin Curated by TDR Targets References
Leishmania major beta tubulin Curated by TDR Targets References
Leishmania major epsilon tubulin, putative Curated by TDR Targets References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis hypothetical protein Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania braziliensis alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis tubulin gamma 1 chain Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma brucei tubulin delta chain Get druggable targets OG5_143817 All targets in OG5_143817
Trichomonas vaginalis tubulin epsilon chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium knowlesi alpha-tubulin II, putative Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit alpha Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium falciparum alpha tubulin 2 Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha 1C chain Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin beta-4 chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin alpha 1C chain Get druggable targets OG5_126605 All targets in OG5_126605
Trichomonas vaginalis tubulin epsilon chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium yoelii tubulin beta chain Get druggable targets OG5_126611 All targets in OG5_126611
Brugia malayi Tubulin beta-1 chain Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium vivax tubulin gamma chain, putative Get druggable targets OG5_127652 All targets in OG5_127652
Echinococcus multilocularis tubulin subunit TubB Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Loa Loa (eye worm) tubulin alpha 2 Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis tubulin alpha 1C chain Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin alpha-2/alpha-4 chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Babesia bovis tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Brugia malayi Tubulin alpha-2 chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania braziliensis beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium falciparum tubulin beta chain Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium yoelii tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma cruzi tubulin delta chain Get druggable targets OG5_143817 All targets in OG5_143817
Trypanosoma cruzi epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Echinococcus granulosus Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania braziliensis epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Leishmania mexicana epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Schistosoma japonicum Tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Neospora caninum hypothetical protein Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit gamma Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania donovani epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Loa Loa (eye worm) alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major gamma-tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Cryptosporidium hominis alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania infantum alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Cryptosporidium parvum gamma tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major delta tubulin, putative Get druggable targets OG5_143817 All targets in OG5_143817
Trypanosoma brucei gambiense zeta tubulin Get druggable targets OG5_145938 All targets in OG5_145938
Toxoplasma gondii beta-1 tubulin, putative Get druggable targets OG5_126611 All targets in OG5_126611
Toxoplasma gondii beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum ko:K10389 tubulin gamma, putative Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma brucei gambiense beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Entamoeba histolytica tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Toxoplasma gondii tubulin/FtsZ family, GTPase domain-containing protein Get druggable targets OG5_143817 All targets in OG5_143817
Echinococcus multilocularis Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Trichomonas vaginalis tubulin gamma chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Loa Loa (eye worm) tubulin alpha-3 chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin beta-1 chain Get druggable targets OG5_126611 All targets in OG5_126611
Cryptosporidium hominis gamma-tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Schistosoma japonicum Tubulin beta-7 chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Entamoeba histolytica tubulin family protein Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin gamma chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium vivax tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma congolense tubulin delta chain Get druggable targets OG5_143817 All targets in OG5_143817
Echinococcus granulosus beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Brugia malayi Tubulin alpha-2 chain Get druggable targets OG5_126605 All targets in OG5_126605
Giardia lamblia Alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei gambiense alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum ko:K10391 tubulin epsilon, putative Get druggable targets OG5_130726 All targets in OG5_130726
Trypanosoma brucei gambiense gamma tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin alpha 3 chain Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania donovani tubulin delta chain Get druggable targets OG5_143817 All targets in OG5_143817
Brugia malayi tubulin alpha chain - mouse Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania braziliensis beta-tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin beta-1 chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium knowlesi alpha tubulin, putative Get druggable targets OG5_126605 All targets in OG5_126605
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Loa Loa (eye worm) tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium berghei tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus tubulin gamma 1 chain Get druggable targets OG5_127652 All targets in OG5_127652
Neospora caninum tubulin delta chain, putative Get druggable targets OG5_143817 All targets in OG5_143817
Entamoeba histolytica tubulin alpha-1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium berghei tubulin gamma chain, putative Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma congolense epsilon tubulin Get druggable targets OG5_130726 All targets in OG5_130726
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania braziliensis gamma-tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma cruzi zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Trichomonas vaginalis tubulin alpha-1 chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium knowlesi tubulin gamma chain, putative Get druggable targets OG5_127652 All targets in OG5_127652
Brugia malayi alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium berghei tubulin epsilon chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Plasmodium yoelii Tubulin/FtsZ family, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha 3 chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania braziliensis beta-tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin alpha 3 chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania braziliensis beta-tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni tubulin subunit alpha Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania infantum beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Schistosoma japonicum ko:K07375 tubulin beta, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium vivax tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Cryptosporidium hominis beta-catenin-like repeat protein Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania mexicana alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Loa Loa (eye worm) beta-tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma brucei gambiense epsilon tubulin Get druggable targets OG5_130726 All targets in OG5_130726
Babesia bovis tubulin beta chain Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania mexicana beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Candida albicans cytoskeletal structural protein Get druggable targets OG5_126605 All targets in OG5_126605
Babesia bovis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum ko:K07374 tubulin alpha, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin epsilon chain Get druggable targets OG5_130726 All targets in OG5_130726
Trypanosoma brucei epsilon tubulin Get druggable targets OG5_130726 All targets in OG5_130726
Trypanosoma brucei gambiense beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania donovani tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Loa Loa (eye worm) tubulin alpha 2 Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum ko:K07375 tubulin beta, putative Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum Tubulin alpha-1 chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei epsilon tubulin Get druggable targets OG5_130726 All targets in OG5_130726
Leishmania infantum beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Giardia lamblia Beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Toxoplasma gondii alpha-tubulin I, putative Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Giardia lamblia Beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Neospora caninum Beta-tubulin, related Get druggable targets OG5_127652 All targets in OG5_127652
Babesia bovis tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Loa Loa (eye worm) tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma cruzi beta tubulin, putative Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania infantum gamma-tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Loa Loa (eye worm) tubulin alpha-2 chain Get druggable targets OG5_126605 All targets in OG5_126605
Theileria parva Tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin alpha 2 Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis peroxisome assembly protein 26 Get druggable targets OG5_126605 All targets in OG5_126605
Brugia malayi Tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Trichomonas vaginalis tubulin, putative Get druggable targets OG5_126611 All targets in OG5_126611
Cryptosporidium parvum alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin beta-4 chain Get druggable targets OG5_126611 All targets in OG5_126611
Toxoplasma gondii alpha tubulin TUBA1 Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin alpha-1C chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium yoelii tubulin beta chain Get druggable targets OG5_130726 All targets in OG5_130726
Echinococcus multilocularis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Toxoplasma gondii beta-tubulin, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium knowlesi tubulin epsilon chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Trichomonas vaginalis tubulin epsilon chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania mexicana beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania mexicana beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126605 All targets in OG5_126605
Theileria parva tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium yoelii tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha 3 chain Get druggable targets OG5_126605 All targets in OG5_126605
Neospora caninum tubulin epsilon chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Theileria parva tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin gamma chain, putative Get druggable targets OG5_127652 All targets in OG5_127652
Toxoplasma gondii tubulin/FtsZ family, GTPase domain-containing protein Get druggable targets OG5_130726 All targets in OG5_130726
Leishmania infantum beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin epsilon chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium vivax tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin, beta 4A class IVa Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei gambiense delta tubulin, putative Get druggable targets OG5_143817 All targets in OG5_143817
Giardia lamblia Beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Brugia malayi tubulin alpha-2 chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Entamoeba histolytica tubulin family protein Get druggable targets OG5_126611 All targets in OG5_126611
Brugia malayi Tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis tubulin beta 1 chain Get druggable targets OG5_126611 All targets in OG5_126611
Candida albicans gamma tubulin-like protein Get druggable targets OG5_127652 All targets in OG5_127652
Loa Loa (eye worm) alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Loa Loa (eye worm) tubulin beta chain Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania braziliensis alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Theileria parva tubulin gamma chain, putative Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma cruzi tubulin delta chain Get druggable targets OG5_143817 All targets in OG5_143817
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania infantum alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus peroxisome assembly protein 26 Get druggable targets OG5_126605 All targets in OG5_126605
Cryptosporidium parvum tubulin beta chain Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania braziliensis delta tubulin, putative Get druggable targets OG5_143817 All targets in OG5_143817
Trypanosoma congolense tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma congolense beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Neospora caninum hypothetical protein Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma congolense zeta tubulin Get druggable targets OG5_145938 All targets in OG5_145938
Leishmania donovani zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma cruzi alpha tubulin, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania infantum beta-tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis Tubulin alpha 1 chain Get druggable targets OG5_126605 All targets in OG5_126605
Trichomonas vaginalis tubulin, putative Get druggable targets OG5_127652 All targets in OG5_127652
Plasmodium falciparum tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania infantum delta tubulin, putative Get druggable targets OG5_143817 All targets in OG5_143817
Trypanosoma brucei tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania mexicana gamma-tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Echinococcus multilocularis tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin beta-2A chain Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus tubulin beta 4A class IVa Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus multilocularis beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania donovani alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania mexicana alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium falciparum alpha tubulin 1 Get druggable targets OG5_126605 All targets in OG5_126605
Trichomonas vaginalis tubulin beta chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit epsilon Get druggable targets OG5_130726 All targets in OG5_130726
Echinococcus multilocularis tubulin epsilon chain Get druggable targets OG5_130726 All targets in OG5_130726
Plasmodium berghei alpha tubulin 2 Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum ko:K07374 tubulin alpha, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Loa Loa (eye worm) BEN-1 protein Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma japonicum Tubulin alpha chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Giardia lamblia Gamma tubulin Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Plasmodium berghei alpha tubulin 1 Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin beta chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus tubulin beta 1 chain Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania braziliensis zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Entamoeba histolytica tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Trypanosoma cruzi zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Leishmania major zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei zeta tubulin Get druggable targets OG5_145938 All targets in OG5_145938
Trichomonas vaginalis tubulin alpha chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Giardia lamblia Epsilon tubulin Get druggable targets OG5_130726 All targets in OG5_130726
Toxoplasma gondii tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Candida albicans gamma tubulin-like protein Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania major beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Neospora caninum tubulin alpha chain Get druggable targets OG5_126605 All targets in OG5_126605
Trichomonas vaginalis tubulin alpha-1 chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin subunit TubB Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Trypanosoma brucei zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Leishmania mexicana beta tubulin Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania mexicana Get druggable targets OG5_126611 All targets in OG5_126611
Schistosoma mansoni alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Leishmania mexicana zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Trypanosoma cruzi epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Trypanosoma congolense alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma japonicum Tubulin beta-1 chain, putative Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus multilocularis tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Echinococcus granulosus Tubulin beta 2C chain Get druggable targets OG5_126611 All targets in OG5_126611
Leishmania major alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Schistosoma mansoni tubulin subunit beta Get druggable targets OG5_126611 All targets in OG5_126611
Brugia malayi beta-tubulin, identical Get druggable targets OG5_126611 All targets in OG5_126611
Trypanosoma cruzi tubulin gamma chain Get druggable targets OG5_127652 All targets in OG5_127652
Leishmania infantum epsilon tubulin, putative Get druggable targets OG5_130726 All targets in OG5_130726
Schistosoma mansoni tubulin subunit alpha Get druggable targets OG5_126605 All targets in OG5_126605
Trichomonas vaginalis tubulin alpha-1 chain, putative Get druggable targets OG5_126605 All targets in OG5_126605
Plasmodium falciparum tubulin epsilon chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Plasmodium vivax tubulin epsilon chain, putative Get druggable targets OG5_130726 All targets in OG5_130726
Leishmania infantum zeta tubulin, putative Get druggable targets OG5_145938 All targets in OG5_145938
Trypanosoma brucei alpha tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Echinococcus granulosus tubulin alpha 1C chain Get druggable targets OG5_126605 All targets in OG5_126605
Giardia lamblia Alpha-tubulin Get druggable targets OG5_126605 All targets in OG5_126605
Neospora caninum hypothetical protein Get druggable targets OG5_126611 All targets in OG5_126611
Loa Loa (eye worm) alpha-tubulin isotype 2 Get druggable targets OG5_126605 All targets in OG5_126605
Loa Loa (eye worm) BEN-1 protein Get druggable targets OG5_126611 All targets in OG5_126611

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Trypanosoma brucei epsilon tubulin epsilon tubulin, putative 470 aa 488 aa 68.0 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin epsilon chain, putative gamma-tubulin 447 aa 479 aa 28.2 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %
Plasmodium falciparum tubulin gamma chain alpha tubulin 451 aa 457 aa 30.9 %
Plasmodium falciparum tubulin gamma chain beta tubulin 443 aa 438 aa 33.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Toxoplasma gondii flap structure-specific endonuclease 1, putative 0.0028 0.0086 0.0189
Brugia malayi MH1 domain containing protein 0.0017 0.0017 0.0044
Loa Loa (eye worm) hypothetical protein 0.0098 0.053 0.0938
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Mycobacterium tuberculosis Probable esterase LipL 0.0106 0.0583 0.1272
Echinococcus granulosus tubulin alpha chain 0.0471 0.2896 0.3371
Schistosoma mansoni nuclear receptor 2DBD-gamma 0.002 0.0038 0.0045
Echinococcus granulosus Tubulin beta 2C chain 0.0625 0.3871 0.4506
Toxoplasma gondii HEAT repeat-containing protein 0.0085 0.0449 0.113
Echinococcus multilocularis hypothetical protein 0.0471 0.2896 0.2896
Giardia lamblia Alpha-tubulin 0.0471 0.2896 0.7424
Mycobacterium ulcerans beta-lactamase 0.0106 0.0583 0.6016
Echinococcus multilocularis Niemann Pick C1 protein 0.0098 0.053 0.053
Trichomonas vaginalis tubulin gamma chain, putative 0.0384 0.2346 0.606
Schistosoma mansoni hypothetical protein 0.0178 0.1038 0.1208
Brugia malayi Pre-SET motif family protein 0.0032 0.0114 0.0294
Trypanosoma brucei apurinic/apyrimidinic endonuclease, putative 0.0056 0.0269 0.0672
Schistosoma mansoni cpg binding protein 0.003 0.0102 0.0119
Leishmania major beta tubulin 0.0625 0.3871 1
Loa Loa (eye worm) hypothetical protein 0.0207 0.1222 0.2162
Trypanosoma cruzi PAB1-binding protein , putative 0.0053 0.0248 0.0617
Entamoeba histolytica Niemann-Pick C1 protein, putative 0.0098 0.053 0.134
Plasmodium falciparum tubulin beta chain 0.0625 0.3871 1
Brugia malayi mbt repeat family protein 0.0046 0.0205 0.0529
Brugia malayi MH1 domain containing protein 0.0017 0.0017 0.0044
Schistosoma mansoni smad 0.0017 0.0017 0.002
Trichomonas vaginalis ap endonuclease, putative 0.0056 0.0269 0.0695
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.0179
Trypanosoma cruzi apurinic/apyrimidinic endonuclease, putative 0.0056 0.0269 0.0672
Echinococcus multilocularis neuropeptide s receptor 0.047 0.2892 0.2892
Plasmodium vivax tubulin beta chain, putative 0.0625 0.3871 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0145 0.0374
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Trichomonas vaginalis PIKK family atypical protein kinase 0.0028 0.0087 0.0223
Schistosoma mansoni alpha tubulin 0.0471 0.2896 0.3371
Loa Loa (eye worm) nuclear hormone receptor family member nhr-1 0.002 0.0038 0.0068
Echinococcus multilocularis Niemann Pick C1 protein 0.014 0.0796 0.0796
Schistosoma mansoni smad1 5 8 and 0.0017 0.0017 0.002
Mycobacterium leprae possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). 0.0034 0.0128 0.0822
Echinococcus multilocularis endonuclease exonuclease phosphatase 0.0194 0.1141 0.1141
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0302 0.1828 0.3236
Trypanosoma cruzi target of rapamycin kinase 3 0.0037 0.0145 0.0351
Schistosoma mansoni smad1 5 8 and 0.0017 0.0017 0.002
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.001 0.0024
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0056 0.0269 0.0665
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.0179
Echinococcus multilocularis diuretic hormone 44 receptor GPRdih2 0.0096 0.0518 0.0518
Brugia malayi beta-tubulin, identical 0.0625 0.3871 1
Trypanosoma cruzi tubulin delta chain 0.0363 0.221 0.5699
Schistosoma mansoni cpg binding protein 0.0028 0.0092 0.0107
Trichomonas vaginalis PIKK family atypical protein kinase 0.0046 0.0205 0.0529
Echinococcus granulosus Tubulin beta 2C chain 0.0625 0.3871 0.4506
Echinococcus granulosus tubulin beta 1 chain 0.0625 0.3871 0.4506
Echinococcus granulosus tubulin delta chain 0.0161 0.0933 0.1086
Schistosoma mansoni FTZ-F1 nuclear receptor-like protein 0.002 0.0038 0.0045
Loa Loa (eye worm) MH1 domain-containing protein 0.0017 0.0017 0.003
Echinococcus multilocularis tubulin, beta 4A class IVa 0.0625 0.3871 0.3871
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Trichomonas vaginalis conserved hypothetical protein 0.0027 0.0081 0.0209
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0046 0.0205 0.053
Schistosoma mansoni tubulin subunit beta 0.0161 0.0933 0.1086
Loa Loa (eye worm) flap endonuclease-1 0.0028 0.0086 0.0152
Echinococcus granulosus geminin 0.0178 0.1038 0.1208
Trypanosoma cruzi epsilon tubulin, putative 0.0384 0.2343 0.6042
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Echinococcus multilocularis TGF beta signal transducer SmadC 0.0017 0.0017 0.0017
Echinococcus granulosus tar DNA binding protein 0.0062 0.0301 0.0351
Schistosoma mansoni chromobox protein 0.0068 0.034 0.0396
Echinococcus multilocularis L aminoadipate semialdehyde 0.0081 0.0425 0.0425
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Echinococcus multilocularis phosphatidylinositol 3 and 4 kinase 0.0016 0.001 0.001
Loa Loa (eye worm) heterochromatin protein 1 0.0068 0.034 0.0602
Leishmania major epsilon tubulin, putative 0.0384 0.2343 0.6042
Brugia malayi chromobox protein homolog 3 0.0038 0.0152 0.0392
Echinococcus granulosus Tubulin alpha 1 chain 0.0471 0.2896 0.3371
Wolbachia endosymbiont of Brugia malayi cell division protein FtsZ 0.0161 0.0933 1
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Echinococcus granulosus histone acetyltransferase MYST2 0.0053 0.0245 0.0286
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.0046 0.0205 0.0506
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0056 0.0269 0.0665
Loa Loa (eye worm) hypothetical protein 0.031 0.1874 0.3318
Plasmodium falciparum tubulin epsilon chain, putative 0.0384 0.2343 0.6039
Trichomonas vaginalis tubulin epsilon chain, putative 0.0471 0.2896 0.7481
Schistosoma mansoni microtubule-associated protein tau 0.1369 0.8591 1
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0677 0.4205 1
Echinococcus multilocularis tubulin alpha chain 0.0471 0.2896 0.2896
Schistosoma mansoni photoreceptor-specific nuclear receptor related 0.002 0.0038 0.0045
Brugia malayi CXXC zinc finger family protein 0.0028 0.0092 0.0237
Brugia malayi mbt repeat family protein 0.0046 0.0205 0.0529
Brugia malayi kap beta 3 protein 0.0016 0.0013 0.0033
Brugia malayi Tubulin alpha-2 chain 0.0471 0.2896 0.7481
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0271 0.163 0.163
Trichomonas vaginalis PIKK family atypical protein kinase 0.0046 0.0205 0.0529
Brugia malayi beta-lactamase family protein 0.0106 0.0583 0.1507
Trypanosoma brucei epsilon tubulin 0.0384 0.2343 0.6042
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.0046 0.0205 0.0506
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Onchocerca volvulus Huntingtin homolog 0.0121 0.0681 0.4571
Brugia malayi Tubulin beta chain 0.019 0.1118 0.2887
Onchocerca volvulus 0.0106 0.0583 0.3913
Mycobacterium ulcerans extragenic suppressor protein SuhB 0.0038 0.0153 0.1111
Trypanosoma brucei tubulin delta chain 0.0363 0.221 0.5699
Echinococcus multilocularis hepatocyte nuclear factor 4 alpha 0.002 0.0038 0.0038
Trypanosoma brucei alpha tubulin 0.0471 0.2896 0.7475
Schistosoma mansoni tubulin subunit epsilon 0.0384 0.2343 0.2727
Echinococcus granulosus expressed conserved protein 0.0092 0.0492 0.0573
Schistosoma mansoni RAR-like nuclear receptor 0.002 0.0038 0.0045
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0145 0.0374
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Trypanosoma cruzi alpha tubulin, putative 0.0471 0.2896 0.7475
Trichomonas vaginalis myo inositol monophosphatase, putative 0.0038 0.0153 0.0395
Echinococcus granulosus microtubule associated protein 2 0.1369 0.8591 1
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0062 0.0301 0.0351
Brugia malayi CHE-14 protein 0.0042 0.0177 0.0457
Echinococcus granulosus Niemann Pick C1 protein 0.014 0.0796 0.0926
Brugia malayi serine/threonine-protein kinase plk-2 0.0092 0.0493 0.1273
Trypanosoma brucei hypothetical protein, conserved 0.0106 0.0583 0.1485
Brugia malayi Nuclear hormone receptor family member nhr-19 0.002 0.0038 0.0099
Trichomonas vaginalis tubulin alpha-1 chain, putative 0.0471 0.2896 0.7481
Echinococcus multilocularis GPCR, family 2 0.0096 0.0518 0.0518
Echinococcus granulosus tubulin alpha chain 0.0471 0.2896 0.3371
Trypanosoma cruzi myo-inositol-1(or 4)-monophosphatase 1, putative 0.0038 0.0153 0.0371
Loa Loa (eye worm) phosphatidylinositol 3 0.0016 0.001 0.0017
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0271 0.163 0.1897
Onchocerca volvulus 0.0046 0.0205 0.1374
Loa Loa (eye worm) beta-LACTamase domain containing family member 0.0106 0.0583 0.1032
Brugia malayi Cell division protein ftsZ 0.0161 0.0933 0.2409
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Onchocerca volvulus Steroid hormone receptor family member cnr14 homolog 0.002 0.0038 0.0257
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Echinococcus multilocularis tubulin alpha 3 chain 0.0471 0.2896 0.2896
Echinococcus granulosus importin subunit beta 1 0.0085 0.0449 0.0522
Schistosoma mansoni smad1 5 8 and 0.0017 0.0017 0.002
Echinococcus multilocularis tubulin gamma 1 chain 0.0384 0.2346 0.2346
Echinococcus multilocularis polycomb protein SCMH1 0.0046 0.0205 0.0205
Leishmania major beta tubulin 0.0625 0.3871 1
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Toxoplasma gondii beta-tubulin, putative 0.0625 0.3871 1
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Loa Loa (eye worm) hypothetical protein 0.0053 0.0248 0.0439
Toxoplasma gondii alpha tubulin TUBA1 0.0471 0.2896 0.7473
Loa Loa (eye worm) hypothetical protein 0.0046 0.0205 0.0363
Plasmodium falciparum tubulin delta chain, putative 0.0161 0.0933 0.2384
Schistosoma mansoni hypothetical protein 0.004 0.0167 0.0195
Trichomonas vaginalis tubulin epsilon chain, putative 0.0625 0.3871 1
Echinococcus granulosus FTZ F1 nuclear receptor protein 0.002 0.0038 0.0045
Leishmania major phosphopantetheinyl transferase-like protein 0.0023 0.0056 0.0119
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0271 0.163 0.2885
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Trichomonas vaginalis tubulin beta-1 chain, putative 0.0161 0.0933 0.2409
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.001 0.0024
Echinococcus granulosus serine:threonine protein kinase PLK1 0.0092 0.0493 0.0573
Brugia malayi Nuclear hormone receptor family member nhr-40 0.002 0.0038 0.0099
Onchocerca volvulus 0.0101 0.0554 0.3715
Plasmodium falciparum tubulin gamma chain 0.0384 0.2346 0.6047
Brugia malayi TAR-binding protein 0.0062 0.0301 0.0778
Brugia malayi RNA binding protein 0.0062 0.0301 0.0778
Trichomonas vaginalis ran, putative 0.0062 0.0307 0.0792
Trichomonas vaginalis conserved hypothetical protein 0.0042 0.0177 0.0456
Echinococcus multilocularis serine:threonine protein kinase PLK1 0.0092 0.0493 0.0493
Loa Loa (eye worm) nuclear hormone receptor family member nhr-14 0.002 0.0038 0.0068
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Schistosoma mansoni hypothetical protein 0.0024 0.0062 0.0072
Mycobacterium tuberculosis Conserved protein 0.0106 0.0583 0.1272
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Echinococcus multilocularis nuclear receptor 2DBD gamma 0.002 0.0038 0.0038
Echinococcus granulosus Tubulin beta 2C chain 0.0625 0.3871 0.4506
Trypanosoma cruzi hypothetical protein, conserved 0.0106 0.0583 0.1485
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Echinococcus multilocularis Tubulin beta 2C chain 0.0625 0.3871 0.3871
Echinococcus multilocularis tubulin subunit beta 0.0625 0.3871 0.3871
Brugia malayi Nuclear hormone receptor family member nhr-19 0.002 0.0038 0.0099
Loa Loa (eye worm) alpha-tubulin 0.0471 0.2896 0.5126
Onchocerca volvulus Heterochromatin protein 1 homolog 0.0038 0.0152 0.1017
Entamoeba histolytica hypothetical protein 0.007 0.0353 0.0882
Brugia malayi Tubulin alpha chain 0.0471 0.2896 0.7481
Echinococcus multilocularis beta LACTamase domain containing family member 0.0106 0.0583 0.0583
Onchocerca volvulus 0.003 0.01 0.0669
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.0046 0.0205 0.0506
Brugia malayi MH2 domain containing protein 0.0017 0.0017 0.0044
Loa Loa (eye worm) tubulin beta-4 chain 0.0625 0.3871 0.6852
Brugia malayi photoreceptor-specific nuclear receptor 0.002 0.0038 0.0099
Giardia lamblia Kinase, PLK 0.0092 0.0493 0.1075
Echinococcus multilocularis tumor protein p63 0.0692 0.4301 0.4301
Echinococcus multilocularis Tubulin beta 2C chain 0.0625 0.3871 0.3871
Echinococcus multilocularis COUP TF:Svp nuclear hormone receptor 0.002 0.0038 0.0038
Echinococcus granulosus importin 5 0.0016 0.0013 0.0015
Toxoplasma gondii LsmAD domain-containing protein 0.0053 0.0248 0.061
Echinococcus multilocularis tubulin subunit TubB 0.0471 0.2896 0.2896
Schistosoma mansoni retinoid-x-receptor (RXR) 0.002 0.0038 0.0045
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Trichomonas vaginalis PIKK family atypical protein kinase 0.0031 0.0108 0.0279
Schistosoma mansoni hypothetical protein 0.0096 0.0518 0.0603
Loa Loa (eye worm) RNA binding protein 0.0062 0.0301 0.0533
Echinococcus granulosus endonuclease exonuclease phosphatase 0.0194 0.1141 0.1328
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0016 0.001 0.0025
Loa Loa (eye worm) tubulin alpha chain 0.0471 0.2896 0.5126
Brugia malayi Pre-SET motif family protein 0.0219 0.1299 0.3356
Echinococcus multilocularis tubulin delta chain 0.0161 0.0933 0.0933
Plasmodium vivax hypothetical protein, conserved 0.0106 0.0583 0.1478
Echinococcus granulosus flap endonuclease 1 0.0028 0.0086 0.01
Echinococcus multilocularis transportin 1 0.0016 0.0013 0.0013
Trypanosoma brucei Importin-beta N-terminal domain/HEAT-like repeat, putative 0.0016 0.0013 0.0008
Echinococcus multilocularis geminin 0.0178 0.1038 0.1038
Trypanosoma cruzi tubulin gamma chain 0.0384 0.2346 0.605
Brugia malayi Importin beta-1 subunit 0.0085 0.0449 0.1159
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Brugia malayi Ligand-binding domain of nuclear hormone receptor family protein 0.002 0.0038 0.0099
Schistosoma mansoni cellular tumor antigen P53 0.0101 0.0554 0.0644
Loa Loa (eye worm) hypothetical protein 0.0085 0.0449 0.0794
Loa Loa (eye worm) tubulin alpha chain 0.0471 0.2896 0.5126
Schistosoma mansoni hypothetical protein 0.004 0.0167 0.0195
Echinococcus multilocularis Mitotic checkpoint protein PRCC, C terminal 0.0125 0.0703 0.0703
Echinococcus granulosus Mitotic checkpoint protein PRCC C terminal 0.0125 0.0703 0.0819
Schistosoma mansoni hypothetical protein 0.0125 0.0703 0.0819
Echinococcus granulosus SAM and MBT domain containing protein 0.0046 0.0205 0.0238
Plasmodium vivax tubulin alpha chain, putative 0.0471 0.2896 0.7473
Brugia malayi GTP-binding nuclear protein RAN/TC4 0.0062 0.0307 0.0793
Loa Loa (eye worm) nuclear hormone receptor family member nhr-31 0.002 0.0038 0.0068
Echinococcus multilocularis Nuclear hormone receptor family member nhr 41 0.002 0.0038 0.0038
Brugia malayi Nuclear hormone receptor family member nhr-14 0.002 0.0038 0.0099
Trichomonas vaginalis flap endonuclease-1, putative 0.0028 0.0086 0.022
Plasmodium vivax tubulin alpha chain, putative 0.0471 0.2896 0.7473
Echinococcus multilocularis flap endonuclease 1 0.0028 0.0086 0.0086
Brugia malayi RNA, U transporter 1 0.0241 0.144 0.3719
Echinococcus granulosus beta LACTamase domain containing family member 0.0106 0.0583 0.0679
Leishmania major beta tubulin 0.0625 0.3871 1
Trichomonas vaginalis penicillin-binding protein, putative 0.0106 0.0583 0.1506
Echinococcus multilocularis FTZ F1 alpha 0.002 0.0038 0.0038
Onchocerca volvulus 0.0106 0.0583 0.3913
Loa Loa (eye worm) BEN-1 protein 0.0625 0.3871 0.6852
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Trichomonas vaginalis tubulin alpha-1 chain, putative 0.0281 0.169 0.4364
Brugia malayi tubulin alpha chain - mouse 0.0471 0.2896 0.7481
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.018
Echinococcus multilocularis histone lysine methyltransferase setb histone lysine methyltransferase eggless 0.0032 0.0114 0.0114
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Echinococcus granulosus neuropeptide s receptor 0.047 0.2892 0.3366
Trypanosoma brucei importin beta-1 subunit, putative 0.0085 0.0449 0.1137
Entamoeba histolytica tubulin gamma chain 0.0384 0.2346 0.6047
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Echinococcus multilocularis microtubule associated protein 2 0.1369 0.8591 0.8591
Schistosoma mansoni phosphatidylinositol 3-and 4-kinase 0.0016 0.001 0.0011
Trypanosoma cruzi flap endonuclease-1 (FEN-1), putative 0.0028 0.0086 0.0197
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0302 0.1828 0.4723
Toxoplasma gondii histone lysine methyltransferase SET/SUV39 0.0032 0.0114 0.0261
Leishmania major beta tubulin 0.0625 0.3871 1
Leishmania major hypothetical protein, conserved 0.0016 0.0013 0.0008
Loa Loa (eye worm) abnormal chemotaxis protein 14 0.0042 0.0177 0.0313
Trypanosoma cruzi importin beta-1 subunit, putative 0.0069 0.0347 0.0874
Schistosoma mansoni alpha tubulin 0.0471 0.2896 0.3371
Schistosoma mansoni hypothetical protein 0.0096 0.0518 0.0603
Echinococcus multilocularis thyroid hormone receptor alpha 0.0145 0.083 0.083
Echinococcus granulosus tubulin alpha chain 0.0471 0.2896 0.3371
Schistosoma mansoni kinase 0.0047 0.0207 0.0241
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0145 0.0374
Plasmodium vivax GTP-binding nuclear protein RAN/TC4, putative 0.0062 0.0307 0.0762
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.018
Echinococcus granulosus tubulin subunit TubB 0.0471 0.2896 0.3371
Echinococcus granulosus tubulin alpha chain 0.0471 0.2896 0.3371
Leishmania major gamma-tubulin 0.0384 0.2346 0.605
Trichomonas vaginalis CAMK family protein kinase 0.0045 0.0199 0.0513
Echinococcus granulosus histone lysine methyltransferase setb 0.0032 0.0114 0.0132
Loa Loa (eye worm) MH2 domain-containing protein 0.0245 0.1462 0.2588
Brugia malayi beta-lactamase 0.0106 0.0583 0.1507
Echinococcus multilocularis dnaJ subfamily B 0.0406 0.2482 0.2482
Echinococcus granulosus neuropeptide receptor A26 0.047 0.2892 0.3366
Trypanosoma cruzi tubulin delta chain 0.0363 0.221 0.5699
Leishmania major beta tubulin 0.0625 0.3871 1
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Plasmodium vivax importin-beta 2, putative 0.0085 0.0449 0.113
Echinococcus granulosus GTP binding nuclear protein Ran 0.0062 0.0307 0.0357
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Brugia malayi beta-lactamase family protein 0.0106 0.0583 0.1507
Schistosoma mansoni cpg binding protein 0.003 0.0102 0.0119
Loa Loa (eye worm) pre-SET domain-containing protein family protein 0.0219 0.1299 0.23
Loa Loa (eye worm) CXXC zinc finger family protein 0.0028 0.0092 0.0162
Loa Loa (eye worm) MH2 domain-containing protein 0.0017 0.0017 0.003
Trichomonas vaginalis tubulin, putative 0.0194 0.1139 0.2943
Loa Loa (eye worm) alpha-tubulin isotype 2 0.031 0.1874 0.3318
Leishmania major delta tubulin, putative 0.0363 0.221 0.5699
Plasmodium falciparum flap endonuclease 1 0.0028 0.0086 0.0189
Schistosoma mansoni histone-lysine n-methyltransferase setb1 0.0032 0.0114 0.0132
Plasmodium falciparum alpha tubulin 1 0.0471 0.2896 0.7473
Brugia malayi hypothetical protein 0.0053 0.0248 0.0641
Giardia lamblia Epsilon tubulin 0.0193 0.1136 0.2776
Schistosoma mansoni histone-lysine n-methyltransferase setb1 0.0032 0.0114 0.0132
Brugia malayi Steroid receptor seven-up type 2 0.002 0.0038 0.0099
Loa Loa (eye worm) beta-lactamase 0.0106 0.0583 0.1032
Brugia malayi MH2 domain containing protein 0.0017 0.0017 0.0044
Schistosoma mansoni hypothetical protein 0.0096 0.0518 0.0603
Trypanosoma brucei alpha tubulin 0.0471 0.2896 0.7475
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Schistosoma mansoni tar DNA-binding protein 0.0062 0.0301 0.0351
Brugia malayi C2-HC type zinc finger protein C.e-MyT1 0.0053 0.0245 0.0634
Trichomonas vaginalis tubulin gamma chain, putative 0.0161 0.0933 0.2409
Echinococcus granulosus Ataxin 2 N terminaldomain containing protein 0.0024 0.0062 0.0072
Loa Loa (eye worm) hypothetical protein 0.0101 0.0554 0.098
Entamoeba histolytica tubulin alpha-1 chain 0.0471 0.2896 0.7473
Schistosoma mansoni scm-relatedprotein containing 4 mbt domains (sfmbt) 0.0046 0.0205 0.0238
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Loa Loa (eye worm) phosphatidylinositol 3 0.0046 0.0205 0.0363
Trichomonas vaginalis importin beta-1, putative 0.0069 0.0347 0.0896
Trypanosoma brucei phosphatidylinositol 3-kinase tor, putative 0.0022 0.005 0.0105
Trichomonas vaginalis tubulin alpha-1 chain, putative 0.019 0.1118 0.2886
Toxoplasma gondii tubulin/FtsZ family, GTPase domain-containing protein 0.0193 0.1136 0.2912
Trichomonas vaginalis D-aminoacylase, putative 0.0106 0.0583 0.1506
Schistosoma mansoni alpha tubulin 0.0471 0.2896 0.3371
Echinococcus granulosus Tubulin alpha 1 chain 0.0471 0.2896 0.3371
Brugia malayi Flap endonuclease-1 0.0028 0.0086 0.0221
Leishmania major beta tubulin 0.0625 0.3871 1
Trypanosoma cruzi myo-inositol-1(or 4)-monophosphatase 1, putative 0.0038 0.0153 0.0371
Toxoplasma gondii ABC1 family protein 0.0106 0.0583 0.1478
Onchocerca volvulus 0.0249 0.149 1
Trypanosoma brucei epsilon tubulin 0.0384 0.2343 0.6042
Loa Loa (eye worm) tubulin gamma chain 0.0384 0.2346 0.4152
Trypanosoma cruzi zeta tubulin, putative 0.0498 0.3068 0.7921
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.018
Giardia lamblia Beta tubulin 0.0625 0.3871 1
Echinococcus multilocularis translational activator gcn1 0.0016 0.0013 0.0013
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Onchocerca volvulus Huntingtin homolog 0.0121 0.0681 0.4571
Loa Loa (eye worm) hypothetical protein 0.0121 0.0681 0.1206
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Schistosoma mansoni steroid hormone receptor ad4bp 0.002 0.0038 0.0045
Echinococcus multilocularis tubulin alpha chain 0.0471 0.2896 0.2896
Schistosoma mansoni Smad4 0.0017 0.0017 0.002
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0271 0.163 0.421
Echinococcus granulosus nuclear receptor 2DBD gamma 0.002 0.0038 0.0045
Giardia lamblia Beta tubulin 0.0625 0.3871 1
Echinococcus granulosus translational activator gcn1 0.0016 0.0013 0.0015
Trypanosoma brucei epsilon tubulin 0.0351 0.2139 0.5514
Trypanosoma brucei beta tubulin 0.0625 0.3871 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0271 0.163 0.1897
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Loa Loa (eye worm) hypothetical protein 0.0121 0.0681 0.1206
Mycobacterium ulcerans fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE 0.0106 0.0583 0.6016
Echinococcus multilocularis Ataxin 2, N terminal,domain containing protein 0.0024 0.0062 0.0062
Trichomonas vaginalis tubulin epsilon chain, putative 0.0471 0.2896 0.7481
Echinococcus multilocularis SAM and MBT domain containing protein 0.0046 0.0205 0.0205
Leishmania major beta tubulin 0.0625 0.3871 1
Schistosoma mansoni myelin transcription factor 1 myt1 0.0053 0.0245 0.0286
Trichomonas vaginalis conserved hypothetical protein 0.0038 0.0152 0.0391
Entamoeba histolytica tubulin family protein 0.0625 0.3871 1
Leishmania major apurinic/apyrimidinic endonuclease-redox protein 0.0056 0.0269 0.0672
Schistosoma mansoni hypothetical protein 0.0406 0.2482 0.2889
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.001 0.0024
Giardia lamblia Beta tubulin 0.0625 0.3871 1
Schistosoma mansoni importin beta-1 0.0085 0.0449 0.0522
Trichomonas vaginalis myo inositol monophosphatase, putative 0.0038 0.0153 0.0395
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0018 0.0022 0.0057
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Brugia malayi alpha-tubulin 0.0471 0.2896 0.7481
Echinococcus granulosus tubulin alpha 3 chain 0.0471 0.2896 0.3371
Schistosoma mansoni hypothetical protein 0.0178 0.1038 0.1208
Trichomonas vaginalis tubulin, putative 0.0625 0.3871 1
Echinococcus granulosus cpg binding protein 0.003 0.0102 0.0119
Schistosoma mansoni chromobox protein 0.0068 0.034 0.0396
Echinococcus multilocularis tubulin alpha chain 0.0471 0.2896 0.2896
Echinococcus multilocularis protein dispatched 1 0.0048 0.0214 0.0214
Mycobacterium tuberculosis Probable conserved lipoprotein 0.0106 0.0583 0.1272
Trichomonas vaginalis inositol monophosphatase, putative 0.0038 0.0153 0.0395
Loa Loa (eye worm) hypothetical protein 0.0053 0.0245 0.0434
Loa Loa (eye worm) TAR-binding protein 0.0062 0.0301 0.0533
Loa Loa (eye worm) tubulin beta-2A chain 0.0625 0.3871 0.6852
Brugia malayi Nuclear hormone receptor family member nhr-3 0.002 0.0038 0.0099
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.001 0.0024
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.007 0.0353 0.0411
Trypanosoma brucei beta tubulin 0.0351 0.2139 0.5514
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Chlamydia trachomatis holo [acyl-carrier protein] synthase 0.0023 0.0056 0.5
Loa Loa (eye worm) hypothetical protein 0.0281 0.169 0.2991
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Trypanosoma brucei zeta tubulin 0.0498 0.3068 0.7921
Schistosoma mansoni hypothetical protein 0.0293 0.1768 0.2059
Trypanosoma cruzi apurinic/apyrimidinic endonuclease 0.0056 0.0269 0.0672
Echinococcus multilocularis mothers against decapentaplegic 5 0.0017 0.0017 0.0017
Loa Loa (eye worm) alpha-tubulin 0.0471 0.2896 0.5126
Echinococcus multilocularis tubulin alpha 1C chain 0.0471 0.2896 0.2896
Giardia lamblia Gamma tubulin 0.0384 0.2346 0.5971
Schistosoma mansoni coup transcription factor 0.002 0.0038 0.0045
Echinococcus granulosus TGF beta signal transducer SmadC 0.0017 0.0017 0.002
Brugia malayi Smad1 0.0017 0.0017 0.0044
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.0046 0.0205 0.0205
Leishmania major hypothetical protein, conserved 0.0053 0.0248 0.0617
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0018 0.0022 0.0057
Echinococcus granulosus tubulin alpha 1C chain 0.0471 0.2896 0.3371
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.0046 0.0205 0.0506
Echinococcus granulosus cadherin EGF LAG seven pass G type receptor 0.0096 0.0518 0.0603
Brugia malayi MH2 domain containing protein 0.0245 0.1462 0.3777
Schistosoma mansoni tubulin subunit gamma 0.0384 0.2346 0.2731
Echinococcus multilocularis tubulin beta 1 chain 0.0625 0.3871 0.3871
Loa Loa (eye worm) hypothetical protein 0.0038 0.0152 0.0268
Echinococcus multilocularis suppression of tumorigenicity 18 protein 0.0053 0.0245 0.0245
Echinococcus multilocularis tubulin alpha 1C chain 0.0471 0.2896 0.2896
Trypanosoma brucei polo-like protein kinase 0.0092 0.0493 0.1251
Echinococcus multilocularis smad 0.0017 0.0017 0.0017
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Echinococcus granulosus nuclear receptor 2DBD gamma 0.002 0.0038 0.0045
Mycobacterium ulcerans cell division protein FtsZ 0.0161 0.0933 1
Leishmania major beta tubulin 0.0625 0.3871 1
Loa Loa (eye worm) tubulin beta chain 0.0625 0.3871 0.6852
Leishmania major beta tubulin 0.0625 0.3871 1
Loa Loa (eye worm) tubulin alpha-2 chain 0.0471 0.2896 0.5126
Echinococcus granulosus inositol monophosphatase 1 0.0038 0.0153 0.0178
Echinococcus granulosus retinoic acid receptor rxr beta a 0.002 0.0038 0.0045
Echinococcus granulosus Tubulin beta 2C chain 0.0625 0.3871 0.4506
Plasmodium falciparum importin beta, putative 0.0085 0.0449 0.113
Trichomonas vaginalis tubulin alpha-1 chain, putative 0.031 0.1874 0.4842
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Trichomonas vaginalis set domain proteins, putative 0.0249 0.149 0.385
Loa Loa (eye worm) transcription factor SMAD2 0.0245 0.1462 0.2588
Echinococcus granulosus Protein patched homolog 1 0.0042 0.0177 0.0206
Entamoeba histolytica tubulin alpha chain, putative 0.0471 0.2896 0.7473
Wolbachia endosymbiont of Brugia malayi fructose-1,6-bisphosphatase 0.0038 0.0153 0.1111
Plasmodium vivax ataxin-2 like protein, putative 0.0053 0.0248 0.061
Trichomonas vaginalis CAMK family protein kinase 0.0092 0.0493 0.1272
Echinococcus granulosus Tubulin beta 2C chain 0.0625 0.3871 0.4506
Echinococcus multilocularis inositol monophosphatase 1 0.0038 0.0153 0.0153
Schistosoma mansoni thyroid hormone receptor 0.0145 0.083 0.0967
Trichomonas vaginalis tubulin, putative 0.019 0.1118 0.2886
Echinococcus granulosus peroxisome assembly protein 26 0.0471 0.2896 0.3371
Schistosoma mansoni sex comb on midleg homolog 0.0046 0.0205 0.0238
Echinococcus multilocularis importin 5 0.0016 0.0013 0.0013
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0102 0.0263
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.018
Plasmodium falciparum alpha tubulin 2 0.0471 0.2896 0.7473
Onchocerca volvulus 0.0043 0.0184 0.1233
Entamoeba histolytica hypothetical protein 0.0023 0.0056 0.0111
Brugia malayi Latrophilin receptor protein 2 0.0096 0.0518 0.1338
Loa Loa (eye worm) latrophilin receptor protein 2 0.0096 0.0518 0.0916
Brugia malayi latrophilin 2 splice variant baaae 0.0207 0.1222 0.3156
Brugia malayi Ligand-binding domain of nuclear hormone receptor family protein 0.002 0.0038 0.0099
Trichomonas vaginalis PIKK family atypical protein kinase 0.0025 0.007 0.0179
Echinococcus multilocularis histone acetyltransferase MYST2 0.0053 0.0245 0.0245
Onchocerca volvulus 0.002 0.0038 0.0257
Trichomonas vaginalis PIKK family atypical protein kinase 0.004 0.0162 0.0418
Brugia malayi Nuclear hormone receptor family member nhr-25 0.002 0.0038 0.0099
Brugia malayi Niemann-Pick C1 protein precursor 0.0098 0.053 0.1369
Leishmania major hypothetical protein, conserved 0.0106 0.0583 0.1485
Schistosoma mansoni serine/threonine protein kinase 0.0092 0.0493 0.0573
Trypanosoma cruzi epsilon tubulin, putative 0.0384 0.2343 0.6042
Loa Loa (eye worm) nuclear hormone receptor family member nhr-41 0.002 0.0038 0.0068
Trichomonas vaginalis PIKK family atypical protein kinase 0.0028 0.0087 0.0223
Loa Loa (eye worm) mbt repeat family protein 0.0046 0.0205 0.0363
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0271 0.163 0.1897
Trypanosoma cruzi hypothetical protein, conserved 0.0106 0.0583 0.1485
Brugia malayi Nuclear hormone receptor family member nhr-49 0.002 0.0038 0.0099
Trichomonas vaginalis tubulin alpha chain, putative 0.0351 0.2139 0.5525
Echinococcus multilocularis beta tubulin 0.0625 0.3871 0.3871
Trichomonas vaginalis chromobox protein, putative 0.0041 0.017 0.0438
Loa Loa (eye worm) hypothetical protein 0.0042 0.0177 0.0313
Loa Loa (eye worm) tubulin alpha-3 chain 0.0281 0.169 0.2991
Leishmania major beta tubulin 0.0625 0.3871 1
Echinococcus granulosus tumor protein p63 0.0692 0.4301 0.5006
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0145 0.0374
Onchocerca volvulus 0.019 0.1118 0.7498
Toxoplasma gondii inositol(myo)-1(or 4)-monophosphatase 2, putative 0.0038 0.0153 0.0364
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.0046 0.0205 0.0506
Leishmania major importin beta-1 subunit, putative 0.0069 0.0347 0.0874
Leishmania major beta tubulin 0.0625 0.3871 1
Loa Loa (eye worm) exodeoxyribonuclease III family protein 0.0056 0.0269 0.0477
Entamoeba histolytica hypothetical protein 0.007 0.0353 0.0882
Trichomonas vaginalis tubulin epsilon chain, putative 0.0161 0.0933 0.2409
Trichomonas vaginalis chromobox protein, putative 0.0068 0.034 0.0878
Echinococcus multilocularis tar DNA binding protein 0.0062 0.0301 0.0301
Schistosoma mansoni ap endonuclease 0.0056 0.0269 0.0313
Schistosoma mansoni ran 0.0062 0.0307 0.0357
Schistosoma mansoni transcription factor LCR-F1 0.007 0.0353 0.0411
Echinococcus multilocularis sterol regulatory element binding protein 0.0042 0.0177 0.0177
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0271 0.163 0.1897
Toxoplasma gondii tubulin/FtsZ family, GTPase domain-containing protein 0.0363 0.221 0.5695
Mycobacterium tuberculosis Probable lipase LipE 0.0106 0.0583 0.1272
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.0046 0.0205 0.0498
Schistosoma mansoni importin-beta 2 0.0016 0.0013 0.0015
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Plasmodium vivax SET domain protein, putative 0.0032 0.0114 0.0261
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Echinococcus granulosus mothers against decapentaplegic 5 0.0017 0.0017 0.002
Entamoeba histolytica tubulin family protein 0.0625 0.3871 1
Trypanosoma brucei ULK family serine/threonine-protein kinase, putative 0.0016 0.0015 0.0013
Echinococcus granulosus L aminoadipate semialdehyde 0.0081 0.0425 0.0494
Echinococcus granulosus beta tubulin 0.0625 0.3871 0.4506
Echinococcus multilocularis tubulin alpha 0.0351 0.2139 0.2139
Trichomonas vaginalis tubulin epsilon chain, putative 0.0625 0.3871 1
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0062 0.0301 0.0533
Brugia malayi Nuclear hormone receptor family member nhr-31 0.002 0.0038 0.0099
Schistosoma mansoni inositol monophosphatase 0.0038 0.0153 0.0178
Mycobacterium leprae conserved hypothetical protein 0.0106 0.0583 0.6016
Schistosoma mansoni tar DNA-binding protein 0.0062 0.0301 0.0351
Onchocerca volvulus 0.0028 0.0092 0.0615
Plasmodium vivax flap endonuclease 1, putative 0.0028 0.0086 0.0189
Mycobacterium tuberculosis Cell division protein FtsZ 0.0161 0.0933 0.2114
Entamoeba histolytica Ran family GTPase 0.0062 0.0307 0.0762
Toxoplasma gondii GTP-binding nuclear protein ran/tc4 0.0062 0.0307 0.0762
Schistosoma mansoni aminoadipate-semialdehyde dehydrogenase 0.0081 0.0425 0.0494
Loa Loa (eye worm) nuclear hormone receptor family member nhr-49 0.002 0.0038 0.0068
Echinococcus granulosus tubulin alpha chain 0.0471 0.2896 0.3371
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.0046 0.0205 0.0239
Onchocerca volvulus 0.0106 0.0583 0.3913
Trichomonas vaginalis tubulin gamma chain, putative 0.0384 0.2343 0.6052
Schistosoma mansoni histone-lysine n-methyltransferase suv9 0.0043 0.0184 0.0214
Brugia malayi Nuclear hormone receptor family member nhr-41 0.002 0.0038 0.0099
Trichomonas vaginalis CAMK family protein kinase 0.0045 0.0199 0.0513
Loa Loa (eye worm) nucleolar RNA-associated protein alpha 0.0905 0.565 1
Schistosoma mansoni tar DNA-binding protein 0.0062 0.0301 0.0351
Schistosoma mansoni tubulin subunit alpha 0.0471 0.2896 0.3371
Brugia malayi exodeoxyribonuclease III family protein 0.0056 0.0269 0.0695
Echinococcus multilocularis beta tubulin 0.0625 0.3871 0.3871
Trypanosoma cruzi zeta tubulin, putative 0.0498 0.3068 0.7921
Mycobacterium tuberculosis Probable hydrolase 0.0106 0.0583 0.1272
Plasmodium falciparum ataxin-2 like protein, putative 0.0053 0.0248 0.061
Brugia malayi nuclear hormone receptor 0.002 0.0038 0.0099
Toxoplasma gondii exonuclease III APE 0.0056 0.0269 0.0665
Echinococcus multilocularis chromobox protein 1 0.0068 0.034 0.034
Leishmania major myo-inositol-1(or 4)-monophosphatase 1, putative 0.0038 0.0153 0.0371
Echinococcus multilocularis FTZ F1 nuclear receptor protein 0.002 0.0038 0.0038
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.0056 0.0269 0.0515
Brugia malayi ecdysteroid receptor 0.002 0.0038 0.0099
Onchocerca volvulus Protein ultraspiracle homolog 0.002 0.0038 0.0257
Trypanosoma brucei GTP-binding nuclear protein rtb2, putative 0.0062 0.0307 0.0769
Trypanosoma brucei beta tubulin 0.0625 0.3871 1
Trichomonas vaginalis Importin beta-1 subunit, putative 0.0069 0.0347 0.0896
Trypanosoma brucei alpha tubulin 0.0471 0.2896 0.7475
Mycobacterium ulcerans lipase LipD 0.0106 0.0583 0.6016
Brugia malayi Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative 0.0106 0.0583 0.1507
Echinococcus granulosus FTZ F1 alpha 0.002 0.0038 0.0045
Schistosoma mansoni nuclear hormone receptor 0.002 0.0038 0.0045
Echinococcus granulosus tubulin alpha 0.0351 0.2139 0.249
Echinococcus multilocularis Tubulin alpha 1 chain 0.0471 0.2896 0.2896
Echinococcus granulosus diuretic hormone 44 receptor GPRdih2 0.0096 0.0518 0.0603
Mycobacterium leprae Probable lipase LipE 0.0106 0.0583 0.6016
Loa Loa (eye worm) nuclear Hormone Receptor family member 0.002 0.0038 0.0068
Brugia malayi hypothetical protein 0.0034 0.0129 0.0332
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Schistosoma mansoni tubulin subunit beta 0.0625 0.3871 0.4506
Brugia malayi hypothetical protein 0.0121 0.0681 0.176
Schistosoma mansoni hypothetical protein 0.0905 0.565 0.6576
Brugia malayi Tubulin alpha chain 0.0161 0.0933 0.2409
Trichomonas vaginalis conserved hypothetical protein 0.0038 0.0152 0.0391
Brugia malayi Calcitonin receptor-like protein seb-1 0.0302 0.1828 0.4723
Echinococcus granulosus alpha tubulin 0.0471 0.2896 0.3371
Schistosoma mansoni thyroid hormone receptor 0.0145 0.083 0.0967
Trichomonas vaginalis tubulin alpha chain, putative 0.019 0.1118 0.2886
Giardia lamblia GTOR 0.0046 0.0205 0.0315
Leishmania major GTP-binding protein, putative 0.0062 0.0307 0.0769
Loa Loa (eye worm) tubulin alpha 2 0.031 0.1874 0.3318
Leishmania major beta tubulin 0.0625 0.3871 1
Trichomonas vaginalis tubulin, putative 0.019 0.1118 0.2886
Schistosoma mansoni ap endonuclease 0.0056 0.0269 0.0313
Leishmania major protein kinase, putative,polo-like protein kinase, putative 0.0092 0.0493 0.1251
Trichomonas vaginalis hypothetical protein 0.0016 0.0013 0.0032
Loa Loa (eye worm) hypothetical protein 0.002 0.0038 0.0068
Trichomonas vaginalis conserved hypothetical protein 0.0015 0.0003 0.0008
Mycobacterium tuberculosis Probable lipase LipD 0.0106 0.0583 0.1272
Echinococcus multilocularis Tubulin alpha 1 chain 0.0471 0.2896 0.2896
Loa Loa (eye worm) hypothetical protein 0.0471 0.2896 0.5126
Echinococcus granulosus tubulin epsilon chain 0.0384 0.2343 0.2727
Loa Loa (eye worm) hypothetical protein 0.0096 0.0518 0.0916
Echinococcus granulosus GPCR family 2 0.0096 0.0518 0.0603
Schistosoma mansoni nuclear hormone receptor nor-1/nor-2 0.002 0.0038 0.0045
Trypanosoma brucei tubulin gamma chain 0.0384 0.2346 0.605
Trichomonas vaginalis tubulin beta chain, putative 0.019 0.1118 0.2886
Entamoeba histolytica hypothetical protein 0.0069 0.0347 0.0866
Treponema pallidum exodeoxyribonuclease (exoA) 0.0056 0.0269 0.2436
Trichomonas vaginalis PIKK family atypical protein kinase 0.0016 0.001 0.0024
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.0106 0.0583 0.0679
Echinococcus granulosus suppression of tumorigenicity 18 protein 0.0053 0.0245 0.0286
Schistosoma mansoni hypothetical protein 0.007 0.0353 0.0411
Echinococcus granulosus dnaJ subfamily B 0.0406 0.2482 0.2889
Loa Loa (eye worm) hypothetical protein 0.0081 0.0425 0.0752
Trypanosoma brucei alpha tubulin 0.0471 0.2896 0.7475
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0271 0.163 0.1897
Leishmania major beta tubulin 0.0625 0.3871 1
Brugia malayi nuclear receptor NHR-88 0.002 0.0038 0.0099
Toxoplasma gondii tubulin/FtsZ family, GTPase domain-containing protein 0.0351 0.2139 0.5511
Echinococcus granulosus tubulin beta 4A class IVa 0.0625 0.3871 0.4506
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0271 0.163 0.163
Brugia malayi Nuclear hormone receptor-like 1 0.002 0.0038 0.0099
Brugia malayi Inositol-1 0.0038 0.0153 0.0395
Leishmania major beta tubulin 0.0625 0.3871 1
Trypanosoma brucei beta tubulin 0.0625 0.3871 1
Trichomonas vaginalis tubulin gamma chain, putative 0.0625 0.3871 1
Schistosoma mansoni histone-lysine n-methyltransferase setb1 0.0032 0.0114 0.0132
Echinococcus multilocularis Tubulin beta 2C chain 0.0625 0.3871 0.3871
Plasmodium falciparum GTP-binding nuclear protein RAN/TC4 0.0062 0.0307 0.0762
Echinococcus granulosus Niemann Pick C1 protein 0.0098 0.053 0.0617
Echinococcus multilocularis tubulin alpha chain 0.0471 0.2896 0.2896
Leishmania major beta tubulin 0.0625 0.3871 1
Trichomonas vaginalis Importin beta-1 subunit, putative 0.0069 0.0347 0.0896
Giardia lamblia Endonuclease/Exonuclease/phosphatase 0.0056 0.0269 0.0485
Schistosoma mansoni hypothetical protein 0.0096 0.0518 0.0603
Schistosoma mansoni Tr4/Tr2 (homologue) 0.002 0.0038 0.0045
Schistosoma mansoni tar DNA-binding protein 0.0062 0.0301 0.0351
Entamoeba histolytica Flap nuclease, putative 0.0028 0.0086 0.0189
Loa Loa (eye worm) beta-tubulin 0.0625 0.3871 0.6852
Brugia malayi hypothetical protein 0.007 0.0353 0.0912
Schistosoma mansoni tubulin subunit delta 0.0161 0.0933 0.1086
Brugia malayi Tubulin beta-1 chain 0.0625 0.3871 1
Mycobacterium tuberculosis Conserved protein 0.0106 0.0583 0.1272
Mycobacterium tuberculosis Conserved protein 0.0106 0.0583 0.1272
Echinococcus granulosus tubulin subunit beta 0.0625 0.3871 0.4506
Schistosoma mansoni inositol monophosphatase 0.0038 0.0153 0.0178
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Trichomonas vaginalis conserved hypothetical protein 0.0161 0.0933 0.2409
Echinococcus granulosus tubulin gamma 1 chain 0.0384 0.2346 0.2731
Trypanosoma brucei flap endonuclease-1 (FEN-1), putative 0.0028 0.0086 0.0197
Loa Loa (eye worm) tubulin alpha 2 0.0119 0.0668 0.1183
Echinococcus granulosus DNA apurinic or apyrimidinic site lyase 0.0056 0.0269 0.0313
Echinococcus multilocularis Tubulin alpha 1 chain 0.0471 0.2896 0.2896
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.0106 0.0583 0.0679
Brugia malayi Tubulin alpha-2 chain 0.0471 0.2896 0.7481
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Entamoeba histolytica hypothetical protein 0.007 0.0353 0.0882
Brugia malayi Heterochromatin protein 1 0.0068 0.034 0.0878
Brugia malayi tubulin alpha-2 chain 0.0471 0.2896 0.7481
Trypanosoma brucei alpha tubulin, putative 0.019 0.1118 0.2869
Plasmodium falciparum ataxin-2 like protein, putative 0.0053 0.0248 0.061
Echinococcus granulosus Nuclear hormone receptor family member nhr 41 0.002 0.0038 0.0045
Trichomonas vaginalis chromobox protein, putative 0.0041 0.017 0.0438
Toxoplasma gondii tubulin, putative 0.0032 0.0115 0.0265
Echinococcus granulosus Smad4 0.0017 0.0017 0.002
Giardia lamblia GTP-binding nuclear protein RAN/TC4 0.0062 0.0307 0.0584
Loa Loa (eye worm) kap beta 3 protein 0.0016 0.0013 0.0023
Loa Loa (eye worm) inositol-1 0.0038 0.0153 0.0271
Schistosoma mansoni tar DNA-binding protein 0.0062 0.0301 0.0351
Loa Loa (eye worm) tubulin alpha 2 0.031 0.1874 0.3318
Echinococcus granulosus polycomb protein SCMH1 0.0046 0.0205 0.0238
Echinococcus granulosus COUP TF:Svp nuclear hormone receptor 0.002 0.0038 0.0045
Schistosoma mansoni hypothetical protein 0.0207 0.1222 0.1422
Trichomonas vaginalis conserved hypothetical protein 0.0161 0.0933 0.2409
Trypanosoma brucei zeta tubulin, putative 0.0498 0.3068 0.7921
Brugia malayi Nuclear hormone receptor family member nhr-25 0.002 0.0038 0.0099
Toxoplasma gondii beta tubulin 0.0625 0.3871 1
Leishmania major zeta tubulin, putative 0.0498 0.3068 0.7921
Mycobacterium ulcerans hypothetical protein 0.0106 0.0583 0.6016
Onchocerca volvulus Polycomb protein Sfmbt homolog 0.0046 0.0205 0.1374
Echinococcus granulosus phosphatidylinositol 3 and 4 kinase 0.0016 0.001 0.0011
Trichomonas vaginalis conserved hypothetical protein 0.0027 0.0081 0.0209
Trichomonas vaginalis penicillin-binding protein, putative 0.0106 0.0583 0.1506
Echinococcus granulosus snurportin 1 0.0905 0.565 0.6576
Trichomonas vaginalis PIKK family atypical protein kinase 0.0046 0.0205 0.0529
Toxoplasma gondii target of rapamycin (TOR), putative 0.0034 0.013 0.0303
Echinococcus multilocularis expressed conserved protein 0.0092 0.0492 0.0492
Leishmania major beta tubulin 0.0625 0.3871 1
Mycobacterium leprae cell division protein FtsZ 0.0161 0.0933 1
Echinococcus multilocularis protein patched 0.0042 0.0177 0.0177
Mycobacterium tuberculosis Probable esterase/lipase LipP 0.0106 0.0583 0.1272
Trypanosoma cruzi GTP-binding nuclear protein rtb2, putative 0.0062 0.0307 0.0769
Loa Loa (eye worm) Smad1 0.0017 0.0017 0.003
Onchocerca volvulus Bile acid receptor homolog 0.002 0.0038 0.0257
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.007 0.0353 0.0353
Loa Loa (eye worm) hypothetical protein 0.0302 0.1828 0.3236
Schistosoma mansoni patched 1 0.0042 0.0177 0.0206
Trypanosoma cruzi beta tubulin, putative 0.0625 0.3871 1
Mycobacterium ulcerans esterase/lipase LipP 0.0106 0.0583 0.6016
Schistosoma mansoni tubulin subunit alpha 0.0161 0.0933 0.1086
Echinococcus granulosus Tubulin alpha 1 chain 0.0471 0.2896 0.3371
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.0056 0.0269 0.2436
Loa Loa (eye worm) nuclear hormone receptor family member nhr-40 0.002 0.0038 0.0068
Loa Loa (eye worm) hypothetical protein 0.003 0.01 0.0176
Onchocerca volvulus 0.0081 0.0425 0.285
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0019 0.0033 0.0061
Mycobacterium tuberculosis Inositol-1-monophosphatase SuhB 0.0034 0.0128 0.0174
Echinococcus granulosus tubulin alpha 1C chain 0.0471 0.2896 0.3371
Echinococcus multilocularis tubulin alpha chain 0.0471 0.2896 0.2896
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.0046 0.0205 0.0498
Leishmania major flap endonuclease-1 (FEN-1), putative 0.0028 0.0086 0.0197
Trypanosoma brucei importin beta-1 subunit, putative 0.0085 0.0449 0.1137
Entamoeba histolytica exodeoxyribonuclease III, putative 0.0056 0.0269 0.0665
Echinococcus multilocularis Smad4 0.0017 0.0017 0.0017
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.0037 0.0145 0.0351
Giardia lamblia Alpha-tubulin 0.0471 0.2896 0.7424
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Echinococcus multilocularis ecdysone induced protein 78C 0.002 0.0038 0.0038
Echinococcus granulosus tubulin alpha 3 chain 0.0471 0.2896 0.3371
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Echinococcus granulosus beta tubulin 0.0625 0.3871 0.4506
Echinococcus multilocularis Tubulin beta 2C chain 0.0625 0.3871 0.3871
Schistosoma mansoni ran 0.0062 0.0307 0.0357
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Trichomonas vaginalis PIKK family atypical protein kinase 0.0027 0.0085 0.0219
Trypanosoma cruzi polo-like protein kinase, putative 0.0092 0.0493 0.1251
Trichomonas vaginalis tubulin alpha chain, putative 0.0625 0.3871 1
Echinococcus multilocularis snurportin 1 0.0905 0.565 0.565
Loa Loa (eye worm) tubulin beta chain 0.0161 0.0933 0.1651
Schistosoma mansoni TGF-beta signal transducer Smad2 0.0017 0.0017 0.002
Toxoplasma gondii histone lysine methyltransferase SET1 0.0055 0.026 0.0642
Loa Loa (eye worm) importin-beta domain-containing protein 0.0016 0.0013 0.0023
Trypanosoma brucei beta tubulin 0.0625 0.3871 1
Toxoplasma gondii beta-1 tubulin, putative 0.0625 0.3871 1
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0015 0.0003 0.0008
Trypanosoma brucei target of rapamycin kinase 3, putative 0.0037 0.0145 0.0351
Entamoeba histolytica hypothetical protein 0.007 0.0353 0.0882
Plasmodium vivax tubulin epsilon chain, putative 0.0384 0.2343 0.6039
Plasmodium vivax delta tubulin, putative 0.0161 0.0933 0.2384
Leishmania major beta tubulin 0.0625 0.3871 1
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.0056 0.0269 0.2436
Echinococcus multilocularis DNA (apurinic or apyrimidinic site) lyase 0.0056 0.0269 0.0269
Schistosoma mansoni tubulin subunit alpha 0.0471 0.2896 0.3371
Echinococcus multilocularis peroxisome assembly protein 26 0.0471 0.2896 0.2896
Echinococcus multilocularis nuclear receptor 2DBD gamma 0.002 0.0038 0.0038
Loa Loa (eye worm) BEN-1 protein 0.0625 0.3871 0.6852
Onchocerca volvulus Heterochromatin protein 1 homolog 0.0041 0.017 0.114
Schistosoma mansoni retinoic acid receptor RXR 0.002 0.0038 0.0045
Echinococcus multilocularis Tubulin beta 2C chain 0.0625 0.3871 0.3871
Schistosoma mansoni niemann-pick C1 (NPC1) 0.0099 0.054 0.0628
Leishmania major beta tubulin 0.0625 0.3871 1
Mycobacterium tuberculosis Possible conserved lipoprotein LpqK 0.0106 0.0583 0.1272
Brugia malayi RNA recognition motif domain containing protein 0.0062 0.0301 0.0778
Trichomonas vaginalis esterase, putative 0.0106 0.0583 0.1506
Brugia malayi Tubulin beta chain 0.0161 0.0933 0.2409
Entamoeba histolytica myo-inositol monophosphatase, putative 0.0038 0.0153 0.0364
Echinococcus multilocularis histone lysine N methyltransferase SETMAR 0.0032 0.0114 0.0114
Trichomonas vaginalis chromobox protein, putative 0.0068 0.034 0.0878
Toxoplasma gondii 4'-phosphopantetheinyl transferase domain-containing protein 0.0023 0.0056 0.0111
Brugia malayi aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase 0.0081 0.0425 0.1097
Schistosoma mansoni tubulin subunit alpha 0.0471 0.2896 0.3371
Echinococcus multilocularis cadherin EGF LAG seven pass G type receptor 0.0096 0.0518 0.0518
Trichomonas vaginalis tubulin alpha chain, putative 0.019 0.1118 0.2886
Plasmodium vivax tubulin gamma chain, putative 0.0384 0.2346 0.6047
Loa Loa (eye worm) hypothetical protein 0.0051 0.0236 0.0419
Trichomonas vaginalis ap endonuclease, putative 0.0056 0.0269 0.0695
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Giardia lamblia Delta tubulin 0.0161 0.0933 0.2238
Leishmania major alpha tubulin 0.0471 0.2896 0.7475
Loa Loa (eye worm) GTP-binding nuclear protein RAN/TC4 0.0062 0.0307 0.0543
Echinococcus granulosus hepatocyte nuclear factor 4 alpha 0.002 0.0038 0.0045
Echinococcus multilocularis importin subunit beta 1 0.0085 0.0449 0.0449
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.0046 0.0205 0.0239
Loa Loa (eye worm) hypothetical protein 0.0106 0.0583 0.1032
Echinococcus granulosus chromobox protein 1 0.0068 0.034 0.0396
Schistosoma mansoni sex comb on midleg homolog 0.0046 0.0205 0.0238
Trichomonas vaginalis PIKK family atypical protein kinase 0.0028 0.0087 0.0223
Loa Loa (eye worm) PLK/PLK1 protein kinase 0.0092 0.0493 0.0872
Trypanosoma cruzi GTP-binding nuclear protein rtb2, putative 0.0062 0.0307 0.0769
Entamoeba histolytica serine/threonine protein kinase, putative 0.0092 0.0493 0.1244
Trichomonas vaginalis PIKK family atypical protein kinase 0.0034 0.013 0.0334
Schistosoma mansoni hypothetical protein 0.004 0.0167 0.0195
Trypanosoma brucei PAB1-binding protein , putative 0.0053 0.0248 0.0617
Trypanosoma brucei inositol-1(or 4)-monophosphatase 1, putative 0.0038 0.0153 0.0371
Trichomonas vaginalis PIKK family atypical protein kinase 0.0027 0.0085 0.0219
Brugia malayi Nuclear hormone receptor family member nhr-1 0.002 0.0038 0.0099
Loa Loa (eye worm) tubulin beta-1 chain 0.0625 0.3871 0.6852
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0145 0.0374
Echinococcus granulosus chromobox protein 1 0.0068 0.034 0.0396
Schistosoma mansoni hypothetical protein 0.004 0.0167 0.0195
Brugia malayi Tubulin gamma chain 0.0384 0.2346 0.606
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.0046 0.0205 0.0506
Echinococcus granulosus transportin 1 0.0016 0.0013 0.0015
Toxoplasma gondii 4'-phosphopantetheinyl transferase superfamily protein 0.0023 0.0056 0.0111
Toxoplasma gondii alpha-tubulin I, putative 0.0471 0.2896 0.7473
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0018 0.0022 0.0057
Loa Loa (eye worm) MBCTL1 0.0053 0.0245 0.0434
Trichomonas vaginalis D-aminoacylase, putative 0.0106 0.0583 0.1506
Echinococcus multilocularis tubulin epsilon chain 0.0384 0.2343 0.2343
Trypanosoma cruzi polo-like protein kinase, putative 0.0092 0.0493 0.1251
Trichomonas vaginalis tubulin beta chain, putative 0.0625 0.3871 1
Echinococcus multilocularis chromobox protein 1 0.0068 0.034 0.034
Trichomonas vaginalis tubulin beta chain, putative 0.0471 0.2896 0.7481
Treponema pallidum cell division protein FtsZ 0.0161 0.0933 1
Echinococcus multilocularis tubulin alpha 3 chain 0.0471 0.2896 0.2896
Echinococcus multilocularis neuropeptide receptor A26 0.047 0.2892 0.2892
Onchocerca volvulus Serine\/threonine kinase homolog 0.0092 0.0493 0.3305
Trichomonas vaginalis D-aminoacylase, putative 0.0106 0.0583 0.1506
Echinococcus granulosus smad 0.0017 0.0017 0.002
Brugia malayi calcium-independent alpha-latrotoxin receptor 2, putative 0.0096 0.0518 0.1338
Loa Loa (eye worm) hypothetical protein 0.0032 0.0114 0.0201
Echinococcus multilocularis GTP binding nuclear protein Ran 0.0062 0.0307 0.0307
Loa Loa (eye worm) steroid hormone receptor 0.002 0.0038 0.0068
Plasmodium vivax holo-[acyl-carrier-protein] synthase, putative 0.0023 0.0056 0.0111
Echinococcus granulosus sterol regulatory element binding protein 0.0042 0.0177 0.0206
Trypanosoma brucei hypothetical protein, conserved 0.0023 0.0056 0.0119
Echinococcus granulosus ecdysone induced protein 78C 0.002 0.0038 0.0045
Trichomonas vaginalis tubulin alpha chain, putative 0.019 0.1118 0.2886
Brugia malayi steroid hormone receptor 0.002 0.0038 0.0099
Schistosoma mansoni flap endonuclease-1 0.0025 0.0069 0.008
Echinococcus granulosus 5'partial|histone lysine N methyltransferase SETDB2 0.003 0.0102 0.0119
Trypanosoma cruzi PAB1-binding protein , putative 0.0053 0.0248 0.0617
Plasmodium falciparum holo-[acyl-carrier-protein] synthase, putative 0.0023 0.0056 0.0111
Echinococcus multilocularis cpg binding protein 0.003 0.0102 0.0102

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

Affected Entity Phenotypic quality Occurs in Occurs at Evidence Observed in Targets
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 26882  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 26953  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 29919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 25756  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 29777  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 25113  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 29099  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 28601  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 24472  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 21739  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 28044  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 21309  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 24440  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 20919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 22594  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 23453  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 21545  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 29554  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 29031  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 23905  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 21179  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 25450  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 22205  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 27459  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 26961  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 22252  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 23996  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 23078  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 20827  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 28024  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania amazonensis 28324  
Annotator: aaronjr@u.washington.edu Comment: Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 7818612
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 26882  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 26953  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 29919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 25756  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 29777  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 25113  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 29099  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 28601  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 24472  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 21739  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 28044  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 21309  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 24440  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 20919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 22594  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 23453  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 21545  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 29554  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 29031  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 23905  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 21179  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 25450  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 22205  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 27459  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 26961  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 22252  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 23996  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 23078  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 20827  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 28024  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 28324  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 26882  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 26953  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 29919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 25756  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 29777  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 25113  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 29099  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 28601  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 24472  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 21739  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 28044  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 21309  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 24440  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 20919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 22594  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 23453  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 21545  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 29554  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 29031  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 23905  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 21179  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 25450  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 22205  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 27459  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 26961  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 22252  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 23996  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 23078  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 20827  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 28024  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 28324  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 26882  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 26953  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 29919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 25756  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 29777  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 25113  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 29099  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 28601  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 24472  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 21739  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 28044  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 21309  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 24440  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 20919  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 22594  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 23453  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 21545  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 29554  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 29031  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 23905  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141
microtubule polymerization (GO:0046785) decreased (PATO:0000468) in vitro (MI:0492) inferred from specific protein inhibition (ECO:0000020) Leishmania donovani 21179  
Annotator: aaronjr@u.washington.edu Comment: Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied References: 12161141